SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Chembio Secures $5.7 Million for Biothreat Test Development

Biosynex subsidiary Chembio secured $5.7 million for biothreat test development.

Related stories